Evaluation of the efficiency of modified PAMAM dendrimer with low molecular weight protamine peptide to deliver IL‐12 plasmid into stem cells as cancer therapy vehicles
Sign Up to like & getrecommendations! Published in 2021 at "Biotechnology Progress"
DOI: 10.1002/btpr.3175
Abstract: Interleukin 12 (IL‐12) is considered as an important molecule for cancer immunotherapy with significant roles in hindering tumor activity, mostly mediated by tumor‐associated macrophages and anti‐angiogenic factors. Mesenchymal stem cells (MSCs) have been come out… read more here.
Keywords: deliver; modified pamam; cancer; efficiency ... See more keywords